Kaviani 2014.
Methods | RCT: IRCT201212101011717 | |
Participants | 80 women randomised Inclusion criteria: primiparous women > 20 weeks' gestation, with mild depression BDI score between 14 to 19, > 18 years of age, not consuming fish more than twice a week#, not suffering from schizophrenia, bipolar disorders, blood disorders, such as Von Willebrand, hypertension, hyperlipidaemia, renal and thyroid diseases, not taking anticoagulants or antidepressants, not smoking or using narcotics, or not participating in activities such as yoga, relaxation, and psychological consultations. #those consuming fish more than twice a week were replaced by the next individual Exclusion criteria: allergic or digestive reactions to study medications Setting: 2 randomly selected health centres in Shiraz, Iran |
|
Interventions |
SUPPLEMENTATION: omega‐3 versus placebo Group 1: omega‐3 LCPUFA: 1 g/day*: total number randomised = 40 Group 2: placebo (olive oil): total number randomised = 40 Timing of supplementation: women in the omega‐3 group were supplemented for 6 weeks** DHA + EPA dose/day: unclear *not further specified **gestational ages not specified apart from being > 20 weeks' gestation |
|
Outcomes | Women/birth: depression during pregnancy (Beck Depression Inventory) | |
Notes | Funding: not reported Declarations of interest: none declared | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: “permuted block randomisation” |
Allocation concealment (selection bias) | Unclear risk | Quote: “permuted block randomisation” |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote: “Both mothers and researchers were blinded to drug and placebo” |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | No losses to follow‐up reported; however women consuming fish more than twice a week were replaced by the next individual (number of instances not reported). |
Selective reporting (reporting bias) | High risk | Only 1 outcome was reported. |
Other bias | Unclear risk | Similar baseline characteristics except that all participants in placebo group were employed, compared with only 5% of participants in the intervention group. |